FDA 510(k) tender compliance checklist: what procurement teams verify

When a hospital tender requires FDA 510(k) clearance for a medical device, the evaluation committee doesn't just check a box. They verify specific documents, cross-reference databases, and flag inconsistencies. Here's exactly what they look for — and where suppliers commonly fail.

The 510(k) verification checklist

1. K-number verification

Every 510(k) clearance has a unique K-number (e.g., K212345). Evaluators verify this number against the FDA's 510(k) Premarket Notification Database. They check:

• Does the K-number exist?
• Does it correspond to the device being offered (same product name, same manufacturer)?
• Is the clearance for the correct product code and device class?
• What is the decision date? (Recent clearances may indicate a new-generation product; very old clearances may raise questions about current manufacturing compliance.)

2. Predicate device and substantial equivalence

The 510(k) summary describes the predicate device — the legally marketed device your product is claimed to be substantially equivalent to. Sophisticated evaluators check whether the predicate is still on the market and whether the substantial equivalence claim covers the specific use case described in the tender.

3. Indications for Use statement

The cleared Indications for Use must cover the clinical application specified in the tender. A device cleared for diagnostic imaging may not cover therapeutic applications, even if the hardware is identical. This is the most common compliance gap — the device is cleared, but not for the specific use the tender requires.

4. Manufacturing facility registration

FDA-cleared devices must be manufactured in FDA-registered facilities. Evaluators can verify facility registration on the FDA Establishment Registration database. If your manufacturing has moved since the 510(k) was cleared, you need updated registration.

5. Adverse event history

Some evaluation frameworks include a check of the FDA MAUDE database (Manufacturer and User Facility Device Experience) for adverse event reports related to the device. A high number of reports relative to the installed base raises questions during evaluation.

6. Post-market requirements

FDA may impose post-market surveillance requirements as a condition of clearance. If your 510(k) has conditions, you need evidence that you're meeting them. Missing post-market data can be grounds for compliance failure.

Common failure points

1. Cleared for the wrong indication: The device is FDA cleared, but the Indications for Use statement doesn't cover the tender's clinical application. This is a substantive compliance gap, not a paperwork issue.
2. Referencing a parent company's clearance: Subsidiaries and distributors sometimes reference a clearance held by the manufacturer. If the tender requires the bidding entity to hold the clearance, a distributor's reference to the OEM's K-number may not satisfy the requirement.
3. Expired or superseded clearance: If a newer model has been cleared under a different K-number, referencing the old clearance for the current model is incorrect.
4. Missing 510(k) summary: Some suppliers provide the clearance letter but not the summary. Evaluators need both — the summary contains the Indications for Use, predicate device, and substantial equivalence determination.

How to strengthen your FDA compliance in tenders

• Always provide the K-number, clearance letter, and 510(k) summary as a package
• Explicitly map the cleared Indications for Use to the tender's clinical requirements
• If your device has multiple clearances (for different indications or configurations), specify which applies to each tender requirement
• Include a compliance matrix showing: tender requirement → applicable K-number → Indications for Use → evidence reference
• Pre-verify your own data against FDA databases before submission — evaluators will